Shire plans to retain few workers in buyout (Roanoke Times)
The news came as the FDA approved the first drug invented by New River Pharmaceuticals. Shire plc, the company that plans to buy New River Pharmaceuticals Inc., intends to close New River's Radford headquarters and Blacksburg research and development division, retaining at best a small number of the company's 46 employees, Shire spokesman Matthew Cabrey said Friday.

Emergent BioSolutions Delivers Approximately 1 Million Doses of BioThrax(R) Ahead of Schedule to U.S. Department of ... (Business Wire via Yahoo! Finance)
ROCKVILLE, Md.----Emergent BioSolutions Inc. announced that yesterday it delivered just under one million doses of BioThrax , the only FDA licensed anthrax vaccine, to the Department of Health and Human Services for placement into the nation's strategic national stockpile .

Theravance Announces FDA Acceptance of Telavancin NDA (Market Wire via Yahoo! Finance)
Theravance, Inc. announced today that the U.S. Food & Drug Administration has accepted the New Drug Application for its investigational antibiotic telavancin for the treatment of complicated skin and skin structure infections caused by Gram-positive organisms, including methicillin-resistant Staphylococcus aureus. The FDA has established a goal of a standard ten-month review of the telavancin ...